Literature DB >> 21532496

Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping.

Martin P Powers1, Karla Alvarez, Hyun-Jung Kim, Federico A Monzon.   

Abstract

Oncocytoma, chromophobe renal cell carcinoma (chRCC), and the eosinophilic variant of clear cell RCC (ccRCC) are morphologically similar tumors with significantly different clinical courses. These renal tumor subtypes show characteristic structural genetic changes; however, the mRNA expression patterns of oncocytoma and chRCC are strikingly similar. MicroRNAs (miRNA) are small RNA molecules that regulate the expression of many genes and have been shown to be useful for tumor classification and identification. The miRNA expression was analyzed from formalin-fixed paraffin-embedded tissue in 5 cases each of oncocytoma, ccRCC, papillary RCC, chRCC, and 4 normal kidney tissues using microarrays. Affymetrix single-nucleotide polymorphism arrays were used to detect chromosomal imbalances in each of the tumors. Eighteen miRNAs were significantly different among the 4 tumor types. The microRNA miR-21, a known oncogenic miRNA, was found to be upregulated in papillary and clear cell carcinomas. Four miRNAs could differentiate oncocytomas from chRCCs and the 3 could differentiate papillary RCC from ccRCC, including miR-126, a known vasculogenic miRNA. Of the 18 differentially expressed miRNAs, only 2 correlated with copy number changes in the chromosomal region harboring these genes. One tumor, originally diagnosed as an oncocytoma by morphology, showed a virtual karyotype and miRNA expression pattern consistent with chromophobe carcinoma. Further investigation of the tumor showed vascular invasion. Our study suggests that miRNA expression can be used to differentiate the common subtypes of renal epithelial neoplasms but further validation is necessary. In addition, the lack of correlation between miRNA expression and virtual karyotype suggests a non-copy-number-related mechanism for miRNA gene expression regulation in renal neoplasia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21532496     DOI: 10.1097/PDM.0b013e3181efe2a9

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  11 in total

1.  A MicroRNA Cluster miR-23-24-27 Is Upregulated by Aldosterone in the Distal Kidney Nephron Where it Alters Sodium Transport.

Authors:  Xiaoning Liu; Robert S Edinger; Christine A Klemens; Yu L Phua; Andrew J Bodnar; William A LaFramboise; Jacqueline Ho; Michael B Butterworth
Journal:  J Cell Physiol       Date:  2017-01-05       Impact factor: 6.384

Review 2.  MicroRNAs and the regulation of aldosterone signaling in the kidney.

Authors:  Michael B Butterworth
Journal:  Am J Physiol Cell Physiol       Date:  2015-02-11       Impact factor: 4.249

Review 3.  The regulation and function of microRNAs in kidney diseases.

Authors:  Qingqing Wei; Qing-Sheng Mi; Zheng Dong
Journal:  IUBMB Life       Date:  2013-07       Impact factor: 3.885

4.  microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion.

Authors:  Amit Bera; Falguni Das; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  Exp Cell Res       Date:  2014-07-09       Impact factor: 3.905

5.  Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.

Authors:  Enrico Munari; Luigi Marchionni; Apurva Chitre; Masamichi Hayashi; Guido Martignoni; Matteo Brunelli; Stefano Gobbo; Pedram Argani; Mohamad Allaf; Mohammad O Hoque; George J Netto
Journal:  Hum Pathol       Date:  2014-01-31       Impact factor: 3.466

6.  Regulation of Aerobic Glycolysis by microRNAs in Cancer.

Authors:  Pankaj K Singh; Kamiya Mehla; Michael A Hollingsworth; Keith R Johnson
Journal:  Mol Cell Pharmacol       Date:  2011

7.  microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.

Authors:  Nirmalya Dey; Falguni Das; Nandini Ghosh-Choudhury; Chandi Charan Mandal; Dipen J Parekh; Karen Block; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

8.  Treatment-independent miRNA signature in blood of Wilms tumor patients.

Authors:  Jana Schmitt; Christina Backes; Nasenien Nourkami-Tutdibi; Petra Leidinger; Stephanie Deutscher; Markus Beier; Manfred Gessler; Norbert Graf; Hans-Peter Lenhof; Andreas Keller; Eckart Meese
Journal:  BMC Genomics       Date:  2012-08-07       Impact factor: 3.969

Review 9.  MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).

Authors:  Ming Li; Ying Wang; Yongsheng Song; Renge Bu; Bo Yin; Xiang Fei; Qizhen Guo; Bin Wu
Journal:  Oncol Rep       Date:  2015-02-13       Impact factor: 3.906

10.  Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma.

Authors:  Celia Prior; Jose Luis Perez-Gracia; Jesus Garcia-Donas; Cristina Rodriguez-Antona; Elizabeth Guruceaga; Emilio Esteban; Cristina Suarez; Daniel Castellano; Aránzazu González del Alba; Maria Dolores Lozano; Joan Carles; Miguel Angel Climent; Jose Angel Arranz; Enrique Gallardo; Javier Puente; Joaquim Bellmunt; Alfonso Gurpide; Jose Maria Lopez-Picazo; Alvaro Gonzalez Hernandez; Begoña Mellado; Esther Martínez; Fernando Moreno; Albert Font; Alfonso Calvo
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.